Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.
Created: 2020-05-30
Updated: 2023-01-19
In July of 2018, Angiex launched an experiment to the International Space Station (ISS) U.S. National Laboratory to test our highly selective cancer therapy that targets both tumor cells and the endothelial cells of tumor blood vessels. Our project was supported by a MassChallenge “Technology in Space Prize,” awarded by the ISS National Laboratory and Boeing.
Miscellaneous, In-Space Manufacturing, Microgravity Science
Launched
yotta
Microgravity Science
Development
Carousel Spacelab
Active Debris Removal (ADR), Microgravity Flight Service (LEO), Microgravity Science
Early stage, ?
KURO
Microgravity Research Payloads, Microgravity Workspaces, Microgravity Science, Microgravity Simulation, In-Space Manufacturing
Microgravity Workspaces, Microgravity Science, ISS Utilization Service, Medical Support
Early stage
Kirara
Microgravity Research Payloads, Microgravity Science, Microgravity Flight Service (LEO)
Active
Microgravity Science, In-Space Manufacturing
Microgravity Flight Service (LEO), Microgravity Science, Microgravity Research Payloads
TETRANITE
Demonstrated
Microgravity Science, Microgravity Research Payloads
BioFoundry
Microgravity Science, Microgravity Simulation
Dormant, Active
SPACTORY
Microgravity Flight Service (LEO), ISS Utilization Service, Microgravity Science
Demonstrated, Active
ScienceTaxi
Microgravity Flight Service (LEO), ISS Utilization Service, Hardware, Microgravity Science